{"subsection_name": null, "pub_date": "2011-10-18T15:04:17Z", "byline": {"original": "By ANDREW POLLACK", "person": [{"lastname": "POLLACK", "organization": "", "rank": 1, "role": "reported", "firstname": "Andrew"}]}, "abstract": "Will more pregnancies be terminated if women can learn through a simple blood test if they are carrying a baby with Down syndrome?", "word_count": 585, "print_page": null, "news_desk": null, "snippet": "Will more pregnancies be terminated if women can learn through a simple blood test if they are carrying a baby with Down syndrome?", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "subject", "value": "Tests (Medical)", "rank": "4"}, {"name": "subject", "value": "Pregnancy and Obstetrics", "rank": "3"}, {"name": "subject", "value": "Down Syndrome", "rank": "2"}, {"name": "type_of_material", "value": "News", "rank": "1"}], "type_of_material": "Blog", "lead_paragraph": "A new test was introduced Monday that can determine if a fetus has Down syndrome using a sample of the mother's blood. The test, and others like it, are expected to reach the market in the coming year and might eventually reduce the need for invasive tests that carry a slight risk of inducing miscarriages.", "web_url": "http://prescriptions.blogs.nytimes.com/2011/10/18/the-quandary-posed-by-a-new-down-syndrome-test/", "section_name": "Health", "headline": {"main": "The Quandary Posed by a New Down Syndrome Test", "kicker": "Prescriptions"}, "slideshow_credits": null, "_id": "4fd3a1af8eb7c8105d8e89e4", "document_type": "blogpost"}